Takeda Emphasizes Diversity, Equity, and Inclusion as Essential Elements of Work Culture to bring Equal Opportunities for all at the G20 Summit
Sep 08, 2023
New Delhi [India], September 8: Takeda Biopharmaceuticals India Pvt. Ltd. (formerly known as Baxalta Bioscience India Private Limited), a global values-based, R&D-driven biopharmaceutical leader, was invited to a dedicated session on diversity, equity, and inclusion (DE&I) conducted in collaboration with the Healthcare Businesswomen's Association (HBA) at the G20 Summit. During this session, experts from Takeda and other healthcare organizations discussed strategies for overcoming challenges that hinder advancements in the DE&I space, provided solutions to facilitate substantial transformation, and shared valuable insights on preparing women for careers and achieving gender parity in the continually evolving healthcare industry.
Read More ..